Skip to Content
Stock Analyst Update

Aphria & Tilray Merge, Form Largest Cannabis Company

We see a strong strategic rationale for the combined company, which will keep the Tilray name.

On Dec. 16, Aphria (APHA) and Tilray (TLRY) announced a merger to form the largest cannabis company in the world by revenue. As we said in our earlier note on speculation of the deal, we see a strong strategic rationale for the combined company, which will keep the Tilray name, including the ability to consolidate production in Canada, combine alcohol and CBD businesses in the United States in preparation for potential federal legalization, and the ability to combine efforts in Europe. We consider the target CAD 100 million of cost synergies as achievable, as they represent just 9% of combined costs and overhead expenses, and we see significant low-hanging fruit.

In a reverse merger structure, Aphria shareholders will receive 0.8381 Tilray shares for each Aphria share, implying a 23% premium to Tilray’s share price before the announcement. Given relative sizes, Aphria shareholders will own about 60% of the combined company and get seven of the nine board seats. Tilray CEO and Chairman Brendan Kennedy will get one of Tilray’s two board seats, while Aphria CEO and Chairman Irwin Simon will keep both roles in the combined company.

We’ve updated our fair value estimates, increasing Aphria’s to $12 and CAD 15 per share from $11 and CAD 14.50, respectively, and Tilray’s to $14 per share from $10. Our no-moat ratings remain unchanged for both companies, reflecting low returns on capital in the near term based on the industry’s infancy.

In addition, we’ve reduced Tilray’s uncertainty rating to very high, in line with most of the cannabis producers we cover, as the deal reduces the risk of value destruction from dilutive equity issuances.

We think the deal favors Tilray because of its 23% premium, and we saw greater upside in Aphria shares before the transaction. Aphria shares were down about 1% and Tilray shares were up 19%, the market confirming our view of Tilray’s lopsided share of the economics. Nevertheless, both stocks look attractive, trading in 4-star territory.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.
Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.